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We detect mutagens by using a special
set of bacterial tester strains. We have de-
scribed our test system for mutagen and
carcinogen detection in a series of recent
papers. I will give here only a summary
of some of these results, omitting references
to other work, which is credited in our
original papers.
A simple procedure for combining human
(or rat) liver for carcinogen activation and
the bacteria for detection and classification
is used. We show that a wide variety of
carcinogens (aflatoxin, benzpyrene, acetyla-
minofluorene, etc.) are frame shift mutagens
after activation and can be detected with
these strains. We explain the structure of
these carcinogens on the basis of the theory
of frameshift mutagenesis. We postulate that
carcinogens cause cancer by somatic mutation
and suggest what the combined bacteria/
liver system be used as a simple procedure
for carcinogen detection.
Construction of Strains for Testing
Mutagens
During the last several years we have de-
veloped a set a tester strains of Salmonella
typhimurium for detecting mutagens (1-4).
This system is supersensitive and simple to
use. The principle of the tester strains is
to use mutants caused by a known type of
DNA damage (base-pair substitutions, and
the various kinds of frameshift mutations)
*Biochemistry Department, University of Califor-
nia, Berkeley, California 94720.
for detecting mutagens by the highly sensi-
tive and convenient back mutation test (re-
version to prototrophy). We have introduced
a deletion of one of the genes of the excision
repair system in all of our tester strains,
and this has made them hundreds of times
more sensitive to most mutagens. We have
made a great improvement in the sensitivity
of the four tester strains by introducing into
each strain a mutation which eliminates the
lipopolysaccharide which coats the surface
of these bacteria and acts as a partial bar-
rier to the penetration of compounds to the
bacterial membrane. This is especially im-
portant for large compounds.
A bacterial test system has many practical
and theoretical advantages in the detection
of mutagens, among which are the small
genome (about 4 x 106 base pairs), the
large number of organisms exposed (about
109/plate), and the positive selection of the
mutated organisms. The set of Salmonella
tester strains has three additional advant-
ages: the lack of excision repair, the loss of
the lipopolysaccharide barrier, and the scor-
ing of mutations in "hot spots" for frame-
shift mutagenesis (e.g., the CGCGCGCG
sequence in tester strain TA1538). The scor-
ing of reversion in easily mutated "hot spots"
combined with the smallness of the genome
aid the test by maximizing reversion re-
lative to killing. Our set of tester strains for
detecting frameshift mutagens is not yet
complete, and we are attempting to complete
the theoretically expected set of frameshift
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tive sequences in DNA.
We have also developed new methodology
(1) for testing mutagens by forward muta-
genesis using strains lacking the excision
repair sytem and the lipopolysaccharide as
an adjunct to our set of tester strains. We
also compare (1) the zones of inhibition on
two strains both of which lack the lipopoly-
saccharide and one of which lack repair.
Use of These Strains for
Detecting Carcinogens
Identification of Activated Carcinogens as
Frameshift Mutagens
It has long been known that many simple
alkylating agents, as well as radiation (ultra-
violet, x-rays, etc.) are both carcinogenic and
mutagenic, and we have shown that a variety
of these agents can be detected with our
tester strain that detects base pair substitu-
tions (1-3). We have found that a large
variety of chemical carcinogens can also
be detected as mutagens with our frame-
shift mutation tester strains. We have iden-
tified these carcinogens as members of a
special class of mutagens: reactive frame-
shift mutagens. An addition or deletion of a
base pair from the DNA (a frameshift muta-
tion) can occur when there is a shifted pair-
ing in a repetitive string of nucleotides, e.g.,
G-G-G-G
C-C-C-C
during DNA replication. This process is enor-
mously increased by the addition of an acri-
dine type compound that intercalates in the
DNA base pair stack and stabilizes the
shifted pairing. A number of years ago we
discovered that when an intercalating agent
(an acridine) also has a side chain that can
react with DNA (a nitrogen half mustard)
it is a more potent mutagen for causing
frameshifts by one to two orders of magni-
tude (4,5).
Polycyclic hydrocsarbons intercalate in
DNA, and it is thought that polycyclic hydro-
carbons are metabolized in mammals to the
epoxides, which are believed to be the pri-
mary carcinogens. We have shown that epox-
ides of the carcinogenic polycyclic hydrocar-
bons are extremely potent frameshift muta-
gens (6) of the reactive type.
In addition to these carcinogens, we have
shown that metabolites of a variety of aro-
matic amine carcinogens are frameshift
mutagens in our system (7). 2-Nitrosofluor-
ene, a known metabolite of 2-aminofluorene
in the rat (and a more effective carcinogen),
is thousands of times more effective as a
frameshift mutagen than the parent com-
pound. The nitroso group is a reactive group,
and we believe, by analogy with the acridine
half mustards, that nitrosofluorene is both
intercalating and reacting with DNA. Be-
cause of this we have tested the nitroso
metabolites of a variety of aromatic amine
carcinogens and have shown that they are
very potent frameshift mutagens (7). Among
these compounds are nitrosonaphalene, nitro-
sobiphenyl, nitroso-trans-stilbene, nitroso-
azobenzene, and nitrosophenanthrene. We
have also repeated the work of Hartman
and shown that 4-nitroquinoline-N-oxide, a
well known carcinogen, is another member
of this class (1).
Detection of Carcinogens and Mutagens:
Mammalian Microsomal Hydroxylase
The true or primary carcinogen or muta-
gen is often a metabolic product of the se-
condary carcinogen or mutagen that was
originally ingested. It is known that the
mammalian liver microsomal hydroxylase
systems are responsible for activating many
classes of carcinogens and mutagens; among
these are aflatoxin, aromatic amines, and
polycyclic hydrocarbons.
We have now coupled a rat and human
liver microsomal hydroxylase system to our
tester strains in a simple manner (8). We
make a mitochondria-free supernatant prep-
aration from rat (or human) liver and
have found that the preparation is stable for
months in the *freezer. We have worked
out conditions for spreading this microsomal
system on our Petri plates along with our
tester bacteria (the enzyme systems are
quite active for a long period of time on our
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of metabolites that are made by the micro-
somal system from a putative carcinogen or
mutagen. Using this coupled system, we
have shown that a large number of carcino-
gens that are not directly mutagenic can
now be detected as mutagens. Among the
carcinogens that are metabolized by liver
to active frameshift mutagens under these
conditions are: aminobiphenyl, amino-and
dimethylamino-trans-stilbene, 2-amino-and
2-acetylaminofluorene, aminoanthracene,
benzidine, aminopyrene, aminochrysene, di-
methylbenzanthracene, benzpyrene, and a-
flatoxin B1. Malling (9) has shown that
dimethylnitrosamine is activated to a pro-
duct that causes base pair substitution. We
believe we can detect all of the major classes
or carcinogens by our method.
The Salmonella test system can detect
carcinogens with great sensitivity. In any
system for detecting mutagens one only
scores mutations in a small part of the ge-
nome. Thus the revertant colonies we see rep-
resent only a tiny fraction (10-2 to 10-4) of
the bacteria mutated. Nevertheless, because
of the sensitivity of the tester strains and the
potency as mutagens of the activated carci-
nogens one can detect nanograms of carci-
nogen: e.g., 0.5 jug of 2-aminoanthracene gives
11,000 revertant colonies per Petri plate,
compared to a control of about 30 colonies
(8).
Characterization of Tester Strains
We have made good progress in charac-
terizing our frameshift tester strains (1).
One of them has a repetitive G sequence at
the site of the mutation, and another has been
shown by Isono and Yourno (in preparation)
to have a repetitive CGCGCGCG sequence.
We are finding that the different carcino-
gens and mutagens have a great deal of spe-
cificity as to the repetitive DNA sequence
that they cause mutations in, and we are con-
structing new frameshift "hot spots" to
complete our set of frameshift tester strains.
Carcinogens are Somatic Mutagens
I believe that the simplest interpretation
of our own and other's work on carcinogens
as mutagens is that carcinogens cause can-
cer because of their action as mutagens. I
think that the principle of the mutagenesis
for a large group of the carcinogens can be
explained by the theory of frameshift mut-
agenesis.
A simple bacterial test can be used to
see if a compound is likely to be a carcinogen
for humans (mammalian testing is, of course,
expensive and takes years). I also think that
the prediction of what will be carcinogenic
can be put on a more rational basis.
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